Showing results (61-70 of 82) with videos related to
Sort By:
Pageof 9
Nanomedicine : Nanotechnology, Biology, and Medicine|April 22, 2017
Modified nanoparticle mediated IL-12 immunogene therapy for colon cancerXiaoxiao Liu, Xiang Gao, Songping Zheng, et al.Cancer Research Communications|June 5, 2024
Activation of the Mevalonate Pathway in Response to Anti-cancer Treatments Drives Glioblastoma Recurrences Through Activation of Rac-1Ling He, Angeliki Ioannidis, Carter J Hoffman, et al.Proceedings of the National Academy of Sciences of the United States of America|February 26, 2025
Radiation-induced cellular plasticity primes glioblastoma for forskolin-mediated differentiationLing He, Daria Azizad, Kruttika Bhat, et al.Biorxiv : the Preprint Server for Biology|August 7, 2023
Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1Ling He, Angeliki Ioannidis, Evelyn Arambula, et al.Journal of the National Cancer Institute|February 27, 2009
In vivo imaging, tracking, and targeting of cancer stem cellsErina Vlashi, Kwanghee Kim, Chann Lagadec, et al.Nature|August 8, 2022
Autoantibody mimicry of hormone action at the thyrotropin receptorBryan Faust, Christian B Billesbølle, Carl-Mikael Suomivuori, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 4, 2019
1-(4-nitrobenzenesulfonyl)-4-penylpiperazine increases the number of Peyer's patch-associated regenerating crypts in the small intestines after radiation injuryKruttika Bhat, Sara Duhachek-Muggy, Renuka Ramanathan, et al.Nature Biotechnology|October 16, 2019
Predicting HLA class II antigen presentation through integrated deep learningBinbin Chen, Michael S Khodadoust, Niclas Olsson, et al.Stem Cells Translational Medicine|August 30, 2019
Radiation mitigation of the intestinal acute radiation injury in mice by 1-[(4-nitrophenyl)sulfonyl]-4-phenylpiperazineSara Duhachek-Muggy, Kruttika Bhat, Paul Medina, et al.Breast Cancer Research : BCR|February 1, 2019
Serum erythropoietin levels, breast cancer and breast cancer-initiating cellsKruttika Bhat, Kiri Sandler, Sara Duhachek-Muggy, et al.Pageof 9